Bermuda

Reimbursed Care Access

Bermuda maintains a restrictive approach to classic psychedelic substances: most psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca) are treated as prohibited controlled drugs with no routine medical prescribing or public reimbursement outside tightly regulated research or licenced importation. Ketamine is recognized as a medical anaesthetic internationally and is used in clinical settings for legitimate medical purposes, but there is no public evidence of an established, reimbursed psychedelic/psychiatric ketamine or esketamine outpatient programme on the island. Government communications emphasise that illegal drugs (including hallucinogens) are prohibited from importation and subject to criminal enforcement. [https://www.gov.bm/print/html/node/13256|Government of Bermuda – Prohibited and restricted goods] [https://gov.bm/public-awareness-fact-sheet|Government of Bermuda – Public Awareness Fact Sheet].